To determine the extent of group A Streptococcus (GAS) infections in sub-Saharan Africa and the serotypes that cause disease, we analyzed surveillance data for 64,741 hospital admissions in Kilifi, Kenya, during 1998–2011. We evaluated incidence, clinical presentations, and emm types that cause invasive GAS infection. We detected 370 cases; of the 369 for which we had data, most were skin and soft tissue infections (70%), severe pneumonia (23%), and primary bacteremia (14%). Overall case-fatality risk was 12%. Incidence of invasive GAS infection was 0.6 cases/1,000 live births among neonates, 101/100,000 person-years among children <1 year of age, and 35/100,000 among children <5 years of age. Genome sequencing identified 88 emm types. GAS ...
Streptococcus agalactiae (Group B Streptococcus, GBS) causes neonatal disease and stillbirth, but it...
Molecular epidemiological data on Group A Streptococcus (GAS) infection in Africa is scarce. We char...
Maternal group B streptococcal (GBS) vaccines under development hold promise to prevent GBS disease ...
To determine the extent of group A Streptococcus (GAS) infections in sub-Saharan Africa and the sero...
To determine the extent of group A Streptococcus (GAS) infections in sub-Saharan Africa and the sero...
To determine the extent of group A Streptococcus (GAS) infections in sub-Saharan Africa and the sero...
To determine the extent of group A Streptococcus (GAS) infections in sub-Saharan Africa and the sero...
To determine the extent of group A Streptococcus (GAS) infections in sub-Saharan Africa and the sero...
Includes bibliographical referencesAsymptomatic children can be a major reservoir of pharyngeal Grou...
We undertook a prospective active surveillance study of invasive group A streptococcal (GAS) disease...
We undertook a prospective active surveillance study of invasive group A streptococcal (GAS) disease...
Molecular epidemiological data on Group A Streptococcus (GAS) infection in Africa is scarce. We char...
Molecular epidemiological data on Group A Streptococcus (GAS) infection in Africa is scarce. We char...
We undertook a prospective active surveillance study of invasive group A streptococcal (GAS) disease...
Streptococcus agalactiae (group B streptococcus, GBS) causes neonatal disease and stillbirth, but it...
Streptococcus agalactiae (Group B Streptococcus, GBS) causes neonatal disease and stillbirth, but it...
Molecular epidemiological data on Group A Streptococcus (GAS) infection in Africa is scarce. We char...
Maternal group B streptococcal (GBS) vaccines under development hold promise to prevent GBS disease ...
To determine the extent of group A Streptococcus (GAS) infections in sub-Saharan Africa and the sero...
To determine the extent of group A Streptococcus (GAS) infections in sub-Saharan Africa and the sero...
To determine the extent of group A Streptococcus (GAS) infections in sub-Saharan Africa and the sero...
To determine the extent of group A Streptococcus (GAS) infections in sub-Saharan Africa and the sero...
To determine the extent of group A Streptococcus (GAS) infections in sub-Saharan Africa and the sero...
Includes bibliographical referencesAsymptomatic children can be a major reservoir of pharyngeal Grou...
We undertook a prospective active surveillance study of invasive group A streptococcal (GAS) disease...
We undertook a prospective active surveillance study of invasive group A streptococcal (GAS) disease...
Molecular epidemiological data on Group A Streptococcus (GAS) infection in Africa is scarce. We char...
Molecular epidemiological data on Group A Streptococcus (GAS) infection in Africa is scarce. We char...
We undertook a prospective active surveillance study of invasive group A streptococcal (GAS) disease...
Streptococcus agalactiae (group B streptococcus, GBS) causes neonatal disease and stillbirth, but it...
Streptococcus agalactiae (Group B Streptococcus, GBS) causes neonatal disease and stillbirth, but it...
Molecular epidemiological data on Group A Streptococcus (GAS) infection in Africa is scarce. We char...
Maternal group B streptococcal (GBS) vaccines under development hold promise to prevent GBS disease ...